Название продукции:1-Bromo-3,5-dimethoxybenzene

IUPAC Name:1-bromo-3,5-dimethoxybenzene

CAS:20469-65-2
Молекулярная формула:C8H9BrO2
Чистота:95%+
Номер в каталоге:CM251184
Молекулярная масса:217.06

Упаковочная единица Доступно для заказа Цена ($) Количество
CM251184-100g in stock ůIJ
CM251184-500g in stock ȃȃȃ

Только для использования в НИОКР..

Форма запроса

   refresh    

Информация о продукции

Номер CAS:20469-65-2
Молекулярная формула:C8H9BrO2
Точка плавления:-
Smiles-код:COC1=CC(OC)=CC(Br)=C1
Плотность:
Номер в каталоге:CM251184
Молекулярная масса:217.06
Точка кипения:246°C at 760 mmHg
Номер Mdl:MFCD06200685
Хранение:Store at room temperature.

Category Infos

Benzenes
Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

Column Infos

Erdafitinib
The Janssen Pharmaceutical Companies of Johnson & Johnson announced on September 8, 2023, that it had submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) to seek approval of Erdafitinib for the treatment of adult patients with locally advanced unresectable or metastatic urothelial carcinoma (UC), harbouring susceptible fibroblast growth factor receptor 3 (FGFR3) genetic alterations, with disease progression during or following at least one line of therapy containing a programmed death receptor-1 (PD-1) or programmed death-ligand 1 (PD-[L]1) inhibitor.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.

Related Products